Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.

Ansell BJ, Watson KE, Fogelman AM.

JAMA. 1999 Dec 1;282(21):2051-7. Review.

PMID:
10591388
2.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program..

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

PMID:
15358046
3.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program..

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

4.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute.; American College of Cardiology Foundation.; American Heart Association..

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

5.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
6.

[Statins in primary prevention of coronary heart disease].

Paulweber B.

Wien Med Wochenschr. 1999;149(5-6):129-38. Review. German.

PMID:
10408004
7.
8.

Cholesterol and atherosclerosis: a contemporary perspective.

Kashyap ML.

Ann Acad Med Singapore. 1997 Jul;26(4):517-23. Review.

PMID:
9395824
9.

Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

Cziraky MJ, Watson KE, Talbert RL.

J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.

PMID:
19891279
10.
11.
12.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Daskalopoulou SS, Mikhailidis DP.

Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.

PMID:
16574035
13.
14.

Cholesterol: precursor to many lipid disorders.

Jones PH.

Am J Manag Care. 2001 Aug;7(9 Suppl):S289-98. Review.

15.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

16.

Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.

Stone NJ, Bilek S, Rosenbaum S.

Am J Cardiol. 2005 Aug 22;96(4A):53E-59E. Review.

PMID:
16098845
17.

Management of hypercholesterolaemia in postmenopausal women.

Davidson MH, Maki KC, Karp SK, Ingram KA.

Drugs Aging. 2002;19(3):169-78. Review.

PMID:
12027776
18.

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

Friday KE.

Exp Biol Med (Maywood). 2003 Jul;228(7):769-78. Review.

PMID:
12876295
19.
20.

Supplemental Content

Support Center